A systematic review and meta-analysis of the effects of community use of oral nutritional supplements on clinical outcomes.

ABSTRACT: The impact of oral nutritional supplements (ONS) on patients with complications (disease related morbidity) requires further exploration. This systematic review included 44 randomised controlled trials (RCT) (29 RCT surgical, 15 RCT medical patients) examining the effect of ONS in community settings on the incidence of complications (n5716, mean age 67 years, range 35-87). ONS (mean intake 588kcal/day, range 125-1750; protein 22g/day, range 0-54; mean energy from protein 22%, range 0-54) were prescribed for a mean 74 days, range 5-365. Most RCT (77%) reported fewer complications in the ONS group versus control. Meta-analysis (39 RCT) showed ONS consumption reduced complications including infections, pressure ulcers, wound and fracture healing (OR 0.68, 95% CI 0.59,0.79; p<0.001). Results showed reductions when ONS were used in hospital and community settings (OR 0.72, 95% CI 0.59,0.87; p=0.001) or just in the community (OR 0.65, 95% CI 0.52, 0.80; p<0.001). Reductions in complications were only seen with high ONS adherence ≥80% (OR 0.63, 95% CI 0.48,0.83; p=0.001) and ready-to-drink ONS (OR 0.69, 95% CI 0.60,0.81; p<0.001). This systematic review and meta-analysis show community-based use of ONS in addition to the diet substantially reduces the incidence of complications. The diversity of ONS, patient populations and complication outcomes within the trials included in this review mean further research is warranted.